Listen "The Research Journal - Issue 14: Weighing up the Effects of Weight-loss Drugs"
Episode Synopsis
For investment professionals only.Novo Nordisk and Eli Lilly’s ground-breaking anti-obesity drugs look set to be transformational for millions of individuals worldwide so what about the likely consequences for other companies in healthcare and beyond?
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.